These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 20491651)
1. Medicinal chemistry of antiviral/anticancer prodrugs subjected to phosphate conjugation. Kalász H; Adem A; Hasan MY; Adeghate E; Ram N; Gulyás Z; Tekes K Mini Rev Med Chem; 2010 Aug; 10(9):822-45. PubMed ID: 20491651 [TBL] [Abstract][Full Text] [Related]
2. Strategies in the designing of prodrugs, taking into account the antiviral and anticancer compounds. Lesniewska-Kowiel MA; Muszalska I Eur J Med Chem; 2017 Mar; 129():53-71. PubMed ID: 28219047 [TBL] [Abstract][Full Text] [Related]
3. Nucleoside Phosphate-Conjugates Come of Age: Catalytic Transformation, Polymerase Recognition and Antiviral Properties. Groaz E; Herdewijn P Curr Med Chem; 2015; 22(34):3980-90. PubMed ID: 26597062 [TBL] [Abstract][Full Text] [Related]
4. Current prodrug design for drug discovery. Hsieh PW; Hung CF; Fang JY Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825 [TBL] [Abstract][Full Text] [Related]
6. Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides. Wagner CR; Iyer VV; McIntee EJ Med Res Rev; 2000 Nov; 20(6):417-51. PubMed ID: 11058891 [TBL] [Abstract][Full Text] [Related]
7. [Modified nucleoside phosphates as precursors of antineoplastic and antiviral compounds in a cell]. Arzumanov AA; Diatkina NB Bioorg Khim; 1996; 22(10-11):777-94. PubMed ID: 9036839 [No Abstract] [Full Text] [Related]
8. Strategies on the development of small molecule anticancer drugs for targeted therapy. Lu YH; Gao XQ; Wu M; Zhang-Negrerie D; Gao Q Mini Rev Med Chem; 2011 Jun; 11(7):611-24. PubMed ID: 21699492 [TBL] [Abstract][Full Text] [Related]
9. Anticancer prodrugs: an overview of major strategies and recent developments. Arpicco S; Dosio F; Stella B; Cattel L Curr Top Med Chem; 2011; 11(18):2346-81. PubMed ID: 21671864 [TBL] [Abstract][Full Text] [Related]
10. X-rays Actuate Anticancer Drugs: Opening New Vistas in Prodrug Therapy. Vaidya SP; Patra M Chembiochem; 2021 Nov; 22(21):2998-3000. PubMed ID: 34406685 [TBL] [Abstract][Full Text] [Related]
11. Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates. Thornton PJ; Kadri H; Miccoli A; Mehellou Y J Med Chem; 2016 Dec; 59(23):10400-10410. PubMed ID: 27559756 [TBL] [Abstract][Full Text] [Related]
12. A novel anticancer theranostic pro-prodrug based on hypoxia and photo sequential control. Feng W; Gao C; Liu W; Ren H; Wang C; Ge K; Li S; Zhou G; Li H; Wang S; Jia G; Li Z; Zhang J Chem Commun (Camb); 2016 Aug; 52(60):9434-7. PubMed ID: 27379361 [TBL] [Abstract][Full Text] [Related]
13. Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMT. Tietze LF; Schmuck K Curr Pharm Des; 2011; 17(32):3527-47. PubMed ID: 22074425 [TBL] [Abstract][Full Text] [Related]
14. Anticancer platinum (IV) prodrugs with novel modes of activity. Chin CF; Wong DY; Jothibasu R; Ang WH Curr Top Med Chem; 2011; 11(21):2602-12. PubMed ID: 22039869 [TBL] [Abstract][Full Text] [Related]
15. Anticancer metallodrugs: where is the next cisplatin? Hanif M; Hartinger CG Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in small molecule prodrugs for cancer therapy. Wang P; Jin X; Cai J; Chen J; Ji M Anticancer Agents Med Chem; 2014 Mar; 14(3):418-39. PubMed ID: 23869777 [TBL] [Abstract][Full Text] [Related]
17. Drug-glycosidation and drug development. Kapoor VK; Kaur A Mini Rev Med Chem; 2013 Apr; 13(4):584-96. PubMed ID: 23244764 [TBL] [Abstract][Full Text] [Related]
18. Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy. Pertusati F; Serpi M; McGuigan C Antivir Chem Chemother; 2012 May; 22(5):181-203. PubMed ID: 22182785 [TBL] [Abstract][Full Text] [Related]